Skip to main content
L

Not yet reviewed: this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

PMA

PMA molecule structurePMA molecule structure
4-Methoxyamphetamine
4-MA, 4-MeOA, Dr Death, Death, Chicken PowderOpen in Piru

PMA is a potent hallucinogen1 with psychedelic properties in the substituted amphetamine class.2 It is found as an adulterant in tablets sold as MDMA3, although its effects differ and do not reliably resemble an entactogenic experience. PMA can cause life-threatening overheating and serotonin syndrome even at moderate doses. PMA sold as ecstasy in pill or capsule form is usually indistinguishable from ecstasy.4

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold10 mg
Light20-40 mg
Moderate40-60 mg
Strong50-60 mg
Heavy60+ mg

Duration

Onset1-2 hours
Total2-4 hours

Subjective Effects

Subjective Effects not written up yet

Reagent Testing

Expected colorimetric results for common reagent tests. Colors show reaction change over 1–2 minutes.

Mecke(ME)
white → green1
Mandelin(MD)
yellow2 → green2 → brown3
Robadope(RB)
orange1 → pink1 → pink2 → brown2 → black2
Liebermann(LB)
white → purple2 → brown2 → black3
Powered by PROtestkit.eu

Pharmacology

Pharmacodynamics

PMA promotes serotonin release and inhibits serotonin reuptake5, with evidence suggesting that reuptake inhibition may be more prominent than its releasing action. It also potently inhibits monoamine oxidase A (MAO-A)6, with no significant effect on MAO-B. Its effects on dopamine and norepinephrine transporters are weak, and rodent studies show a robust increase in brain serotonin but only a small increase in dopamine. PMA has very low affinity for 5-HT1A, 5-HT2A, and 5-HT2C receptors, but substantially higher affinity for mouse and rat TAAR1.7

Pharmacokinetics

Human studies detected unchanged PMA in urine after administration, demonstrating that some of the substance is excreted without being metabolized.

Metabolitesnone documented yet

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

2C-T-x compounds5-MeO-xxT tryptaminesAMTAlcoholCaffeineCannabisCocaineDOx compoundsDXMKetamineMAOIsMethoxetamineNBOMe compoundsOpioidsPCPTramadol
Powered by TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Toxicity

Lethal Dosage

PMA can cause potentially fatal increases in temperature and blood pressure at 60–80 mg, and overdose may occur only slightly above the usual recreational dose range. Susceptibility varies substantially between individuals; a dose causing mild effects in one person may be fatal in another. Severe hyperthermia is the most common cause of PMA-related death.8

Cardiovascular system

PMA ingestion can cause severe tachycardia, irregular heartbeat, and hypertension; doses as low as 60 mg can produce substantial increases in pulse and blood pressure.

Thermoregulatory system

PMA can cause life-threatening hyperthermia and serotonin syndrome even at moderate doses, with severe hyperthermia also occurring during overdose.

Metabolic system

Severe hypoglycaemia accompanied by hyperkalaemia was reported in two patients with confirmed PMA poisoning.9

Skeletal muscle

PMA overdose can sometimes cause rhabdomyolysis.10

Brain

PMA overdose can sometimes cause cerebral hemorrhage requiring emergency surgery.

Respiratory system

PMA can cause labored breathing.

Seizure Risk

PMA ingestion has been associated with seizures, and convulsions are a characteristic feature of overdose.

History & Culture

Early research and circulation

Early human studies investigated whether PMA might account for psychosis associated with chronic amphetamine use.11 The proposed explanation was not supported by the studies.11…

Legality

International

PMA (1-(4-methoxyphenyl)propan-2-amine) is internationally controlled in Schedule I of the Convention on Psychotropic Substances of 1971.

By Country

Illegal32
United States flagUnited StatesIllegal
Argentina flagArgentinaIllegal
Australia flagAustraliaIllegal
Austria flagAustriaIllegal
Belgium flagBelgiumIllegal
Brazil flagBrazilIllegal
Canada flagCanadaIllegal
Chile flagChileIllegal
Denmark flagDenmarkIllegal
Finland flagFinlandIllegal
Germany flagGermanyIllegal
India flagIndiaIllegal
Indonesia flagIndonesiaIllegal
Ireland flagIrelandIllegal (analog/blanket ban)
Italy flagItalyIllegal
Japan flagJapanIllegal
Mexico flagMexicoIllegal
Netherlands flagNetherlandsIllegal
New Zealand flagNew ZealandIllegal
Norway flagNorwayIllegal
Philippines flagPhilippinesIllegal
Poland flagPolandIllegal
Portugal flagPortugalIllegal
Russia flagRussiaIllegal
Singapore flagSingaporeIllegal
South Korea flagSouth KoreaIllegal
Spain flagSpainIllegal
Sweden flagSwedenIllegal
Switzerland flagSwitzerlandIllegal
Thailand flagThailandIllegal
Ukraine flagUkraineIllegal
United Kingdom flagUnited KingdomIllegal
Controlled / restricted2
China flagChinaRestricted
Colombia flagColombiaRestricted
Legal / decriminalized1
Czech Republic flagCzech RepublicLegal (regulated)

References

Source Pages

  1. DrugBank: PMA
  2. Erowid
  3. Erowid: PMA Vault
  4. Isomer Design (TiHKAL/PiHKAL)
  5. PsychonautWiki
  6. The Drug Classroom
  7. TripSit Factsheets
  8. Wikipedia

Citations

  1. Drug Awareness Sheets. Royal Canadian Mounted Police (2015). https://www.oha-pda.ca/wcm-docs/docs/documents/rcmp_fiches_sheets_eng.pdf1
  2. Dancing with “Death”: P-Methoxyamphetamine Overdose and Its Acute Management. Journal of Toxicology: Clinical Toxicology (2003). https://doi.org/10.1081/clt-1200191301
  3. Synthesis and characterization of MDMA and development of field-deployable methods for its detection and quantification within Ecstasy tablets. Manchester Metropolitan University (2019). https://doi.org/10.83056/mmu.324777781
  4. Paramethoxyamphetamine (PMA). National Drug and Alcohol Research Centre (2016). https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/NDA073%20Fact%20Sheet%20PMA.pdf1
  5. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue. The Journal of Pharmacology and Experimental Therapeutics (1976). https://pubmed.ncbi.nlm.nih.gov/127128012
  6. Amphetamine Derivatives as Monoamine Oxidase Inhibitors. Frontiers in Pharmacology (2019). https://doi.org/10.3389/fphar.2019.0159012
  7. Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology (2014). https://doi.org/10.1016/j.neuropharm.2013.11.00812345
  8. PARAMETHOXYAMPHETAMINE (PMA). EDCentral (2012). https://edcentral.co/wp-content/uploads/2022/05/Paramethoxyamphetamine_PMA.pdf1
  9. Poisoning with the recreational drug paramethoxyamphetamine ("death"). The Medical Journal of Australia (2001). https://doi.org/10.5694/j.1326-5377.2001.tb143329.x1
  10. PARAMETHOXYAMPHETAMINE. JoDrugs (n.d.). https://www.jodrugs.com/toxicologies/3311-paramethoxyamphetamine.aspx12

Further Reading

  1. Alcohol and Drug Foundation - PMA and PMMA
  2. Caldicott et al. 2003 - Dancing with Death: PMA Overdose
  3. DrugWise: PMA Factsheet
  4. Lurie et al. 2011 - Severe paramethoxymethamphetamine (PMMA) and paramethoxyamphetamine (PMA) outbreak in Israel
  5. Staack & Maurer 2005 - Metabolism of Designer Drugs of Abuse
  6. Nichols et al. 1982 - Effects of certain hallucinogenic amphetamine analogs on the release of [3H]-serotonin from rat brain synaptosomes
  7. Corrigall et al. 1992 - The reinforcing and discriminative stimulus properties of para-ethoxy- and para-methoxyamphetamine

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed: this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the PMA article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.